MX2010001848A - Derivados de oxadiazol como inhibidores de diacilglicerolaciltrans ferasa (dgat). - Google Patents
Derivados de oxadiazol como inhibidores de diacilglicerolaciltrans ferasa (dgat).Info
- Publication number
- MX2010001848A MX2010001848A MX2010001848A MX2010001848A MX2010001848A MX 2010001848 A MX2010001848 A MX 2010001848A MX 2010001848 A MX2010001848 A MX 2010001848A MX 2010001848 A MX2010001848 A MX 2010001848A MX 2010001848 A MX2010001848 A MX 2010001848A
- Authority
- MX
- Mexico
- Prior art keywords
- alkyl
- alkoxy
- sub
- ring
- bromo
- Prior art date
Links
- 101150042222 DGAT1 gene Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 150000004866 oxadiazoles Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 7
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 abstract 4
- 125000003545 alkoxy group Chemical group 0.000 abstract 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000001246 bromo group Chemical group Br* 0.000 abstract 2
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 2
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 2
- 125000001153 fluoro group Chemical group F* 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 108010001348 Diacylglycerol O-acyltransferase Proteins 0.000 abstract 1
- 102000002148 Diacylglycerol O-acyltransferase Human genes 0.000 abstract 1
- 102100036869 Diacylglycerol O-acyltransferase 1 Human genes 0.000 abstract 1
- 101000927974 Homo sapiens Diacylglycerol O-acyltransferase 1 Proteins 0.000 abstract 1
- 229940100228 acetyl coenzyme a Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000001924 cycloalkanes Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Se proporcionan compuestos de fórmula (l), o sales y/o profármacos farmacéuticamente aceptables de los mismos, que inhiben la acetil-CoA (acetilcoenzima A): actividad de diacilglicerolaciltransferasa (DGAT1), en donde n es O a 3; p es O 6 1; q es O a 2; R1 y R2 son, por ejemplo, independientemente fluoro, cloro, bromo, ciano o alquilo (1 a 4 átomos de carbono); X es -O-, -S- o -NRa- en donde Ra es hidrógeno o alquilo (1 a 4 átomos de carbono); RA1 y RA2 son, por ejemplo, independientemente hidrógeno o alquilo (1 a 4 átomos de carbono); el anillo A es un anillo di-enlazado o sistema de anillo elegido de cicloalcano (4 a 6 átomos de carbono), bicicloalcano (7 a 10 átomos de carbono) y tricicloalcano (8 a 12 átomos de carbono) cada uno sustituido opcionalmente, por ejemplo, por un sustituyente seleccionado de alquilo (1 a 4 átomos de carbono), alcoxi (1 a 4 átomos de cárbono) y alcoxi (1 a 4 átomos de carbono)-alquilo (1 a 4 átomos de carbono); o el anillo A es fenileno sustituido opcionalmente, por ejemplo, por hasta cuatro sustituyentes seleccionados de fluoro, cloro, bromo, ciano, alquilo (1 a 4 átomos de carbono), alcoxi (1 a 4 átomos de carbono) y alcoxi (1 a 4 átomos de carbono)-alquilo (1 a 4 átomos de carbono); junto con procesos para su preparación, composiciones farmacéuticas que los contienen y su uso como medicamentos.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95649007P | 2007-08-17 | 2007-08-17 | |
| US99097007P | 2007-11-29 | 2007-11-29 | |
| PCT/GB2008/050716 WO2009024821A2 (en) | 2007-08-17 | 2008-08-15 | Oxadiazole derivatives as dgat inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010001848A true MX2010001848A (es) | 2010-03-10 |
Family
ID=40261963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010001848A MX2010001848A (es) | 2007-08-17 | 2008-08-15 | Derivados de oxadiazol como inhibidores de diacilglicerolaciltrans ferasa (dgat). |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20110092547A1 (es) |
| EP (1) | EP2190840A2 (es) |
| JP (1) | JP2010536839A (es) |
| KR (1) | KR20100057068A (es) |
| CN (1) | CN101827842A (es) |
| AU (1) | AU2008290327A1 (es) |
| BR (1) | BRPI0815490A2 (es) |
| CA (1) | CA2695434A1 (es) |
| MX (1) | MX2010001848A (es) |
| RU (1) | RU2010102990A (es) |
| WO (1) | WO2009024821A2 (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008523133A (ja) | 2004-12-14 | 2008-07-03 | アストラゼネカ アクチボラグ | Ｄｇａｔ阻害剤としてのオキサジアゾール誘導体 |
| US7749997B2 (en) | 2005-12-22 | 2010-07-06 | Astrazeneca Ab | Pyrimido [4,5-B] -Oxazines for use as DGAT inhibitors |
| EP2301923B1 (en) | 2006-03-31 | 2016-06-08 | Novartis AG | Pyridine derivatives as dgat inhibitors |
| ATE492541T1 (de) | 2006-05-30 | 2011-01-15 | Astrazeneca Ab | Substituierte 5-phenylamino-1,3,4-oxadiazol-2- ylcarbonylamino-4-phenoxycyclohexancarbonsäuren als inhibitoren von acetylcoenzym-a- diacylglycerolacyltransferase |
| CA2667545A1 (en) * | 2006-10-25 | 2008-05-02 | Neurosearch A/S | Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators |
| AR066169A1 (es) | 2007-09-28 | 2009-07-29 | Novartis Ag | Derivados de benzo-imidazoles, utiles para trastornos asociados con la actividad de dgat |
| CA2764013A1 (en) | 2009-06-19 | 2010-12-23 | Astrazeneca Ab | Pyrazine carboxamides as inhibitors of dgat1 |
| AU2011253058A1 (en) * | 2010-05-13 | 2012-12-06 | Amgen Inc. | Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors |
| FR2963005B1 (fr) * | 2010-07-23 | 2012-08-17 | Sanofi Aventis | Derives d'oxadiazoles et de pyridazines, leur preparation et leur application en therapeutique |
| CN104245696A (zh) * | 2012-02-07 | 2014-12-24 | 凯诺斯医药公司 | 作为1型二酰基甘油o-酰基转移酶的抑制剂的化合物 |
| WO2014054053A1 (en) * | 2012-10-03 | 2014-04-10 | Advinus Therapeutics Limited | Spirocyclic compounds, compositions and medicinal applications thereof |
| TW201609651A (zh) * | 2013-11-12 | 2016-03-16 | 陶氏農業科學公司 | 用於氟化化合物之過程（一） |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3245989A (en) * | 1962-12-15 | 1966-04-12 | Acraf | 3-aminophenyl-5-aminoloweralkyl-1, 2, 4-oxadiazoles |
| US4983731A (en) * | 1989-03-17 | 1991-01-08 | Nebraska Department Of Economic Development | Separation and purification of sugar esters |
| CA2020888A1 (en) * | 1989-07-27 | 1991-01-28 | Philippe Guerry | Substituted aminoalkoxybenzene derivatives |
| US5491172A (en) * | 1993-05-14 | 1996-02-13 | Warner-Lambert Company | N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents |
| US20030167483A1 (en) * | 1998-06-24 | 2003-09-04 | Farese Robert V. | Diacylglycerol O-acyltransferase |
| WO2000058491A1 (en) * | 1999-03-25 | 2000-10-05 | The Kitasato Institute | Novel substances kf-1040t4a, kf-1040t4b, kf-1040t5a and kf-1040t5b and process for producing the same |
| GB0021670D0 (en) * | 2000-09-04 | 2000-10-18 | Astrazeneca Ab | Chemical compounds |
| CA2369967A1 (en) * | 2001-02-12 | 2002-08-12 | Joseph Anthony Cornicelli | Methods of treating nuclear factor-kappa b mediated diseases and disorders |
| PT1425014E (pt) * | 2001-08-31 | 2007-03-30 | Sanofi Aventis Deutschland | Derivados diarilcicloalquilo, processo para a sua preparação como activadores de ppar |
| FR2840301B1 (fr) * | 2002-05-29 | 2007-03-23 | Sanofi Synthelabo | Derives de phenyl-cyclohexyl-propanolamine, leur preparation et leur applicaton en therapeutique |
| AU2003249937A1 (en) * | 2002-07-12 | 2004-02-02 | Sanofi-Aventis Deutschland Gmbh | Heterocyclically substituted benzoylureas, method for their production and their use as medicaments |
| SE0301010D0 (sv) * | 2003-04-07 | 2003-04-07 | Astrazeneca Ab | Novel compounds |
| WO2005013907A2 (en) * | 2003-08-07 | 2005-02-17 | Japan Tobacco Inc. | Pyrrolo[1,2-b]pyridazine derivatives |
| GB0325192D0 (en) * | 2003-10-29 | 2003-12-03 | Astrazeneca Ab | Method of use |
| CA2566184A1 (en) * | 2004-05-10 | 2005-11-17 | Banyu Pharmaceutical Co., Ltd. | Imidazopyridine compound |
| US20070249620A1 (en) * | 2004-07-02 | 2007-10-25 | Hitoshi Kurata | Urea Derivative |
| WO2006014012A2 (en) * | 2004-08-06 | 2006-02-09 | Otsuka Pharmaceutical Co., Ltd. | Aromatic compounds |
| JP2008523133A (ja) * | 2004-12-14 | 2008-07-03 | アストラゼネカ アクチボラグ | Ｄｇａｔ阻害剤としてのオキサジアゾール誘導体 |
| WO2006082952A1 (ja) * | 2005-02-01 | 2006-08-10 | Takeda Pharmaceutical Company Limited | アミド化合物 |
| MX2007015759A (es) * | 2005-06-11 | 2008-02-21 | Astrazeneca Ab | Derivados de oxadiazol como inhibidores de diacilglicerol aciltransferasa (dgat). |
| AU2006316560B2 (en) * | 2005-11-28 | 2011-06-16 | Madrigal Pharmaceuticals, Inc. | Inhibitors of diacyglycerol acyltransferase (DGAT) |
| US7749997B2 (en) * | 2005-12-22 | 2010-07-06 | Astrazeneca Ab | Pyrimido [4,5-B] -Oxazines for use as DGAT inhibitors |
| US8003676B2 (en) * | 2006-05-30 | 2011-08-23 | Astrazeneca Ab | 1,3,4-oxadiazole derivatives as DGAT1 inhibitors |
| ATE492541T1 (de) * | 2006-05-30 | 2011-01-15 | Astrazeneca Ab | Substituierte 5-phenylamino-1,3,4-oxadiazol-2- ylcarbonylamino-4-phenoxycyclohexancarbonsäuren als inhibitoren von acetylcoenzym-a- diacylglycerolacyltransferase |
| JP2009539816A (ja) * | 2006-06-06 | 2009-11-19 | アストラゼネカ アクチボラグ | 化学化合物 |
| GB0611507D0 (en) * | 2006-06-10 | 2006-07-19 | Astrazeneca Ab | Chemical compounds |
| GB0611506D0 (en) * | 2006-06-10 | 2006-07-19 | Astrazeneca Ab | Chemical compounds |
| US7569590B2 (en) * | 2006-09-19 | 2009-08-04 | Bristol-Myers Squibb Company | Use of thianecarboxamides as dgat inhibitors |
| US8058299B2 (en) * | 2007-05-22 | 2011-11-15 | Via Pharmaceuticals, Inc. | Diacylglycerol acyltransferase inhibitors |
| WO2009081195A1 (en) * | 2007-12-20 | 2009-07-02 | Astrazeneca Ab | Carbamoyl compounds as dgat1 inhibitors 190 |
| JP2012512860A (ja) * | 2008-12-19 | 2012-06-07 | アストラゼネカ アクチボラグ | １，３，４−オキサジアゾール誘導体および糖尿病を処置するそれらの使用 |
-
2008
- 2008-08-15 MX MX2010001848A patent/MX2010001848A/es not_active Application Discontinuation
- 2008-08-15 WO PCT/GB2008/050716 patent/WO2009024821A2/en not_active Ceased
- 2008-08-15 EP EP08788687A patent/EP2190840A2/en not_active Withdrawn
- 2008-08-15 US US12/673,767 patent/US20110092547A1/en not_active Abandoned
- 2008-08-15 BR BRPI0815490A patent/BRPI0815490A2/pt not_active IP Right Cessation
- 2008-08-15 CA CA2695434A patent/CA2695434A1/en not_active Abandoned
- 2008-08-15 KR KR1020107005832A patent/KR20100057068A/ko not_active Withdrawn
- 2008-08-15 CN CN200880112466A patent/CN101827842A/zh active Pending
- 2008-08-15 JP JP2010521485A patent/JP2010536839A/ja active Pending
- 2008-08-15 AU AU2008290327A patent/AU2008290327A1/en not_active Abandoned
- 2008-08-15 RU RU2010102990/04A patent/RU2010102990A/ru not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009024821A3 (en) | 2009-04-09 |
| RU2010102990A (ru) | 2011-09-27 |
| BRPI0815490A2 (pt) | 2017-03-21 |
| CN101827842A (zh) | 2010-09-08 |
| US20110092547A1 (en) | 2011-04-21 |
| KR20100057068A (ko) | 2010-05-28 |
| EP2190840A2 (en) | 2010-06-02 |
| AU2008290327A1 (en) | 2009-02-26 |
| WO2009024821A2 (en) | 2009-02-26 |
| JP2010536839A (ja) | 2010-12-02 |
| CA2695434A1 (en) | 2009-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2010001848A (es) | Derivados de oxadiazol como inhibidores de diacilglicerolaciltrans ferasa (dgat). | |
| NO20084732L (no) | Substituerte 5-fenylamino- 1, 3, 4-oksadiazol-2-ylcarbonylamino-4-fenoksy-cycloheksane karboksylsyre som inhibitorer av acetyl koenzym A diacylglyserol acyltransferase | |
| NO20084663L (no) | 1,3,4-oksadiazol-derivater som DGAT1 inhibitorer | |
| MX2011012061A (es) | Derivados de 7-aza-espiro [3.5] nonano-7-carboxilatos, su preparacion y su uso en terapéutica. | |
| NO20073325L (no) | Nye naftalenforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| WO2008157234A3 (en) | Mono and bis-ester derivatives of pyridinium and quinolinium compounds as environmentally friendly corrosion inhibitors | |
| MX337714B (es) | Derivado de imidazol de heteroanillo fusionado que tiene efecto de activacion de proteina cinasa activada por monofosfato de adenosina (amk). | |
| WO2007137008A3 (en) | Compounds for the treatment of metabolic disorders | |
| NO20085216L (no) | Benzimidazoler og deres anvendelse i behandlingen av diabetes | |
| WO2008087611A3 (en) | Pyrrolidine- and piperidine- bis-amide derivatives | |
| MX2011012059A (es) | Derivados de ciclopenta [c] pirrol-2-carboxilatos, su preparación y su uso en terapeutica. | |
| BRPI1007456A2 (pt) | derivados de azaespiranil-alquilcarbamatos de compostos heterocíclicos com 5 membros, o respectivo preparo e a respectiva aplicação em terapêutica | |
| BR112014004235A2 (pt) | derivados de isoxazolina como compostos inseticidas | |
| AR083017A1 (es) | Prodrogas de ester de [3-(1-(1h-imidazol-4-il)etil)-2-metilfenil]metanol | |
| MX2009010837A (es) | Nuevos compuestos heterociclicos nitrogenados, su preparacion y su utilizacion como medicamentos antibacterianos. | |
| CO6150157A2 (es) | Derivados de 7-alquinil-1,8- naftiridonas su preparacion y su aplicacion en terapeutica | |
| PH12013501572A1 (en) | 5-(phenyl/pyridinyl-ethinyl)-2-pyridine/ 2-pyrimidine-carborxamides as mglur5 modulators | |
| MX2012006789A (es) | Derivados de etinilo. | |
| MX2011012057A (es) | Derivados de ciclopenta [c] pirrolilalquilcarbamatos de heterociclos de 5 miembros, su preparación y su uso en terapéutica. | |
| MX2011014018A (es) | Pirazincarboxamidas como inhibidores de dgati. | |
| BR112013001534A2 (pt) | derivados de oxadiazol e piridazina, suas preparações e suas aplicações em terapêutica | |
| MX2011007272A (es) | Piperidinas de aroilamino y heteroaroilamino sustituidas como inhibidores de glyt-1. | |
| MY161992A (en) | Novel tetrahydroisoquinoline derivative | |
| MX2011011246A (es) | Derivados de 1-h-pirazolo [4,3-c] isoquinoleinas, su preparacion y su uso en terapeutica. | |
| WO2008031771A3 (en) | 3-azabicyclo [4. 1. 0] heptane derivatives for the treatment of depression |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |